Ethos Technologies Inc. Income Taxes Disclosure
11. Income Taxes
The Company files income tax returns in the U.S. federal, Singapore, India and various state jurisdictions.
Income before income tax expense for the years ended December 31, 2025 and 2024 was as follows:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Domestic source |
|
$ |
74,712 |
|
|
$ |
52,414 |
|
Foreign source |
|
|
1,032 |
|
|
|
1,522 |
|
Income before income tax expense |
|
$ |
75,744 |
|
|
$ |
53,936 |
|
The components of the Company’s income tax expense (benefit) are as follows:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Current: |
|
|
|
|
|
|
||
Federal |
|
$ |
(190 |
) |
|
$ |
61 |
|
State |
|
|
(238 |
) |
|
|
743 |
|
Foreign |
|
|
399 |
|
|
|
393 |
|
Total current expense |
|
|
(29 |
) |
|
|
1,197 |
|
Deferred: |
|
|
|
|
|
|
||
Federal |
|
|
3,332 |
|
|
|
3,240 |
|
State |
|
|
1,290 |
|
|
|
667 |
|
Total deferred expense |
|
|
4,622 |
|
|
|
3,907 |
|
Total expense |
|
$ |
4,593 |
|
|
$ |
5,104 |
|
Beginning in the fiscal year ended December 31, 2025 annual reporting, the Company adopted ASU 2023-09 prospectively. See Note 2 for additional details on the adoption of ASU 2023-09. A reconciliation of the U.S. federal statutory income tax rate to our effective tax rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|||||
Income tax expense at U.S. federal statutory tax rate |
|
$ |
15,906 |
|
|
|
21.0 |
% |
State and local income tax, net of federal income tax effect (1) |
|
|
1,102 |
|
|
|
1.5 |
% |
Foreign tax effects |
|
|
399 |
|
|
|
0.5 |
% |
Effect of cross-border tax laws |
|
|
|
|
|
|
||
Foreign tax credit |
|
|
(547 |
) |
|
|
(0.7 |
)% |
Tax credits |
|
|
|
|
|
|
||
Research and development tax credits |
|
|
(334 |
) |
|
|
(0.4 |
)% |
Changes in valuation allowance |
|
|
(12,111 |
) |
|
|
(16.0 |
)% |
Nontaxable and nondeductible items |
|
|
|
|
|
|
||
Share-based payment awards |
|
|
(1,060 |
) |
|
|
(1.4 |
)% |
Other |
|
|
460 |
|
|
|
0.6 |
% |
Changes in unrecognized tax benefits |
|
|
|
|
|
|
||
Uncertain tax benefit on research and development tax credits |
|
|
(235 |
) |
|
|
(0.3 |
)% |
Other |
|
|
|
|
|
|
||
True-ups related to prior year adjustments |
|
|
1,013 |
|
|
|
1.3 |
% |
Total income tax expense |
|
$ |
4,593 |
|
|
|
6.1 |
% |
The following is a reconciliation of income taxes computed at the U.S. federal statutory rate to the income taxes reported in the consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2024:
|
|
Year Ended December 31, |
|
||
|
|
|
2024 |
|
|
Book income before tax |
|
|
$ |
53,936 |
|
Federal tax at statutory rate |
|
|
|
21.0 |
% |
Stock-based compensation |
|
|
|
0.1 |
% |
Change in valuation allowance |
|
|
|
(18.5 |
)% |
State taxes |
|
|
|
2.3 |
% |
Research and development credits |
|
|
|
2.8 |
% |
Non-deductible expenses and other |
|
|
|
0.1 |
% |
Prior year true ups |
|
|
|
1.6 |
% |
Foreign taxes |
|
|
|
0.0 |
% |
Adjustments to net operating losses |
|
|
|
0.0 |
% |
Foreign tax credits |
|
|
|
0.0 |
% |
Tax expense |
|
|
$ |
5,104 |
|
The tax effects of temporary differences giving rise to deferred income tax assets and liabilities as of December 31, 2025 and 2024 were as follows:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Accruals and reserves |
|
$ |
34 |
|
|
$ |
21 |
|
Net operating loss carryforwards |
|
|
65,331 |
|
|
|
62,001 |
|
Asset basis differences |
|
|
2,239 |
|
|
|
7,358 |
|
Lease liability |
|
|
586 |
|
|
|
670 |
|
Settlements |
|
|
357 |
|
|
|
577 |
|
Credit carryforwards |
|
|
3,584 |
|
|
|
2,480 |
|
Equity based compensation |
|
|
3,061 |
|
|
|
2,794 |
|
|
|
|
75,192 |
|
|
|
75,901 |
|
Valuation allowance |
|
|
(25,724 |
) |
|
|
(39,699 |
) |
Deferred tax assets, net of valuation allowance |
|
|
49,468 |
|
|
|
36,202 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
||
Other prepaids |
|
|
(815 |
) |
|
|
(432 |
) |
Right-of-use asset |
|
|
(544 |
) |
|
|
(650 |
) |
Commission receivable |
|
|
(56,638 |
) |
|
|
(39,027 |
) |
|
|
|
(57,997 |
) |
|
|
(40,109 |
) |
Net deferred tax liabilities |
|
$ |
(8,529 |
) |
|
$ |
(3,907 |
) |
The Company records a valuation allowance to reduce deferred tax assets to the amount management believes is more likely than not to be realized. The utilization of deferred tax assets is limited by the amount of taxable income expected to be generated within the allowable carryforward period and other factors. Management also considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. The net decrease in the total valuation allowance for the year ending December 31, 2025 was $13,975, primarily from changes in temporary differences and current year pre-tax book income. The net decrease in the total valuation allowance for the year ending December 31, 2024 is $10,603, primarily from the net operating losses generated.
Cash paid for income taxes, net of refunds received, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows:
|
|
Year Ended December 31, |
|
|
|
|
2025 |
|
|
Federal taxes paid |
|
$ |
400 |
|
States and local taxes paid |
|
|
|
|
California |
|
|
430 |
|
Texas |
|
|
171 |
|
Other |
|
|
209 |
|
Total state and local taxes paid |
|
|
810 |
|
Foreign taxes paid |
|
|
|
|
India |
|
|
550 |
|
Total income taxes paid |
|
$ |
1,760 |
|
The Company had the following tax loss and credit carryforwards as of December 31, 2025 and 2024:
|
|
2025 |
|
|
Beginning |
|
U.S. federal loss carryforwards |
|
$ |
269,993 |
|
|
|
U.S. state and local loss carryforwards |
|
$ |
158,410 |
|
|
|
Federal research and development credit |
|
$ |
4,216 |
|
|
|
State research and development credit |
|
$ |
1,757 |
|
|
Indefinite |
|
|
2024 |
|
|
Beginning |
|
U.S. federal loss carryforwards |
|
$ |
255,959 |
|
|
|
U.S. state and local loss carryforwards |
|
$ |
146,636 |
|
|
|
Federal research and development credit |
|
$ |
3,653 |
|
|
|
State research and development credit |
|
$ |
1,778 |
|
|
Indefinite |
Federal and state tax laws impose substantial restrictions on the utilization of net operating loss and credit carryforwards in the event of an "ownership change" for tax purposes, as defined in Section 382 of the Internal Revenue code. Accordingly, the Company's ability to utilize these carryforwards may be limited as a result of such ownership changes. Such a limitation could result in limitation in the use of the net operating losses in future years and possibly a reduction of the net operating losses available. Based on ownership changes that have occurred through December 31, 2025, the Company has reduced net operating losses available by $2,600 and research and development tax credits by $1,200. This reduction had no impact on tax expense due to the offsetting impact of the valuation allowance.
The Company’s tax returns are subject to the normal statute of limitations, three years from the filing date for federal income tax purposes. The federal and state statute of limitations generally remain open for years in which tax losses are generated until three years from the year those losses are utilized. Under these rules, the 2016 and later year NOLs of Ethos Technologies Inc. are still subject to audit by the IRS and state and local jurisdictions. The December 31, 2022 and later period Singapore returns of Ethos Singapore Pte Ltd. are subject to exam by the Singapore tax authorities. The March 31, 2023 and later period India returns of Ethos International Holdings LLC are subject to exam by the Indian tax authorities.
The following table summarizes the Company’s unrecognized tax benefit activity during the years ended December 31, 2025 and 2024, excluding the related accrual for interest:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Balance at beginning of period |
|
$ |
3,002 |
|
|
$ |
3,383 |
|
Additions (reductions) for tax positions taken in prior |
|
|
(325 |
) |
|
|
(515 |
) |
Additions for tax positions taken in the current year |
|
|
309 |
|
|
|
134 |
|
Balance at end of period |
|
$ |
2,986 |
|
|
$ |
3,002 |
|
The Company records interest and penalties, if any, as a component of its income tax expense in the consolidated statements of operations and comprehensive income (loss). No interest expense or penalties were recognized during the years ended December 31, 2025 and 2024.
On July 4, 2025, the One Big Beautiful Bill Act was signed into law. The legislation did not have a material impact on the Company’s income tax expense for the year ended December 31, 2025, nor did it materially change the Company’s effective income tax rate for 2025.
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.